These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17116139)

  • 1. Acute infection of Toxoplasma gondii and cytomegalovirus reactivation in a pediatric patient receiving liver transplant.
    Galván Ramírez ML; Castillo-de-León Y; Espinoza-Oliva M; Bojorques-Ramos MC; Rodríguez-Pérez LR; Bernal Redondo R; Cañedo-Solares I; Espinoza López L; Correa D
    Transpl Infect Dis; 2006 Dec; 8(4):233-6. PubMed ID: 17116139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary cytomegalovirus infection after combined cadaveric transplantation of the liver and kidney].
    Slavicek J; Puretić Z; Glavas-Boras S; Smalcelj R; Barisić I; Vuković J; Seso-Simić D; Slavicek V; Humar I; Kes P
    Acta Med Croatica; 2003; 57(1):87-90. PubMed ID: 12876872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
    Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
    Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
    Shah T; Lai WK; Mutimer D
    Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
    Madan RP; Campbell AL; Shust GF; Kahn AR; Wistinghausen B; Posada R; Kerkar N; Shneider BL; Emre S; Herold BC
    Transplantation; 2009 May; 87(9):1318-24. PubMed ID: 19424031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Should recurrent Cytomegalovirus infections in patients with liver transplantation be treated?].
    Tarp BD; Astrup LB
    Ugeskr Laeger; 1997 May; 159(22):3413-6. PubMed ID: 9199030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation.
    Slifkin M; Ruthazer R; Freeman R; Bloom J; Fitzmaurice S; Fairchild R; Angelis M; Cooper J; Barefoot L; Rohrer R; Snydman DR
    Liver Transpl; 2005 Dec; 11(12):1597-602. PubMed ID: 16315314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation.
    Stein DS; Verano AS; Levandowski RA
    Am J Gastroenterol; 1988 Jun; 83(6):684-6. PubMed ID: 2837082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prevention and treatment of cytomegalovirus infection after liver transplantation].
    Zheng SS; Jiang ZJ; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Lu AW
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):584-6. PubMed ID: 15938930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
    Basse G; Esposito L; Mengelle C; Kamar N; Ribes D; Lavayssière L; Pillet A; Suc B; Barange K; Rostaing L
    Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras.
    Boucher A; Lord H; Collette S; Morin M; Dandavino R
    Transplant Proc; 2006 Dec; 38(10):3506-8. PubMed ID: 17175316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature.
    Egli A; Bergamin O; Müllhaupt B; Seebach JD; Mueller NJ; Hirsch HH
    Transpl Infect Dis; 2008 Feb; 10(1):27-43. PubMed ID: 18086275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of disseminated cytomegalovirus infection and pneumonitis in a heart transplant recipient by skin biopsy: case report.
    Rees AP; Meadors M; Ventura HO; Pankey GA
    J Heart Lung Transplant; 1991; 10(2):329-32. PubMed ID: 1851636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late cytomegalovirus disease with atypical presentation in renal transplant patients: case reports.
    Boobes Y; Al Hakim M; Dastoor H; Bernieh B; Abdulkhalik S
    Transplant Proc; 2004; 36(6):1841-3. PubMed ID: 15350493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial cytomegalovirus prophylaxis with ganciclovir: no guarantee for prevention of late serious manifestations of CMV after solid organ transplantation.
    Zandberg M; de Maar EF; Hofker HS; Homan van der Heide JJ; Rosati S; van Son WJ
    Neth J Med; 2005 Nov; 63(10):408-12. PubMed ID: 16301763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests.
    Fica A; Cervera C; Pérez N; Marcos MA; Ramírez J; Linares L; Soto G; Navasa M; Cofan F; Ricart MJ; Pérez-Villa F; Pumarola T; Moreno A
    Transpl Infect Dis; 2007 Sep; 9(3):203-10. PubMed ID: 17511827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gancyclovir prophylaxis in high risk patients.
    Campino A
    Transplant Proc; 2005 Dec; 37(10):4311-2. PubMed ID: 16387106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation.
    Meers S; Lagrou K; Theunissen K; Dierickx D; Delforge M; Devos T; Janssens A; Meersseman W; Verhoef G; Van Eldere J; Maertens J
    Clin Infect Dis; 2010 Apr; 50(8):1127-34. PubMed ID: 20218875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal disseminated toxoplasmosis in a cardiac transplantation with seropositive match for Toxoplasma: should prophylaxis be extended?
    Castagnini M; Bernazzali S; Ginanneschi C; Marchi B; Maccherini M; Tsioulpas C; Tanganelli P
    Transpl Immunol; 2007 Nov; 18(2):193-7. PubMed ID: 18005867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.